Analgesic effect of dexamethasone combined with ropivacaine in thoracic paravertebral nerve block after thoracoscopic lobectomy: a randomized, double-blind, prospective study

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000033956

Enrollment

Unknown

Registered

2020-06-18

Start date

2020-06-18

Completion date

Unknown

Last updated

2020-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer

Interventions

Group A:Ropivacaine + dexamethasone

Group B:Ropivacaine

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: 1. Aged 18-60 years; 2. ASA grade: I-II patients; 3. Lung cancer patients who underwent unilateral thoracoscopic lobectomy.

Exclusion criteria

Exclusion criteria: 1. Patients allergic to dexamethasone or ropivacaine; 2. Patients with abnormal coagulation before operation; 3. Patients with skin infection or damage at the puncture site; 4. BMI 30kg / m2; 5. Patients with bradycardia, atrioventricular block and cardiac insufficiency; 6. Patients with serious damage to liver and kidney function; 7. Patients with a history of chronic pain.

Design outcomes

Primary

Measure	Time frame
heart rate;MAP;BIS;VAS;	—

Secondary

Measure	Time frame
Ramsay Score;	—

Countries

China

Contacts

Public ContactWang Fangjun

Affiliated Hospital of North Sichuan Medical College

wfjlxy006@126.com+86 13458253172

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026